InvestorsHub Logo
Followers 50
Posts 9243
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Sunday, 09/29/2024 11:43:41 PM

Sunday, September 29, 2024 11:43:41 PM

Post# of 13634
Multiple key late-stage readouts are on the way as well. Moderna should report phase 3 results for cytomegalovirus (CMV) vaccine mRNA-1647 as early as year-end. It's also on track to begin generating data later this year from pivotal studies of mRNA-3705 and mRNA-3927 targeting metabolic disorders methylmalonic acidemia and propionic acidemia, respectively.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News